Manus builds fermentation and bioprocess infrastructure to commercialize sustainable molecular alternatives. The tech stack—Python, PyTorch, TensorFlow, MATLAB, plus specialized analytical tools (HPLC, LC-MS, GC-MS)—reflects a biotech R&D operation with computational modeling at its core. Active projects span enzyme engineering, protein design, metabolic pathway analysis, and facility buildout, paired with internal focus on yield and cycle-time optimization—the operational bottlenecks that define the 'valley of death' between lab proof-of-concept and manufacturing scale.
Manus is a Boston-based biotech scale-up founded in 2011, operating a platform to accelerate commercialization of bio-based alternatives to petroleum, plant, and animal-derived molecules. The company works with industrial partners across pharma, specialty chemicals, and consumer goods to de-risk the transition from bench chemistry to full-scale biomanufacturing. At 51–200 employees, the organization is weighted toward research and manufacturing roles, supported by in-house analytics, engineering, and commercial teams. Core IP centers on process development, enzyme optimization, and analytical method design.
Python, PyTorch, TensorFlow, MATLAB, and R. Alongside computational stacks, the team uses HPLC, LC-MS, and GC-MS for analytical validation of protein variants and metabolic pathway deconvolution.
Manus is headquartered in Boston, MA and hires exclusively in the United States. The company operates 51–200 employees as a privately held firm.
Other companies in the same industry, closest in size